Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Search Results Details (273)

SortShow
Name Institution Why
David Crittenden Hooper, M.D.Massachusetts General Hospital Why?
A. Thomas Look, M.D.Dana-Farber Cancer Institute Why?
David Allen Reardon, M.D.Dana-Farber Cancer Institute Why?
Nathan Judson McDannold, Ph.D.Brigham and Women's Hospital Why?
Chang-Bin Jing, Ph.D.Boston Children's Hospital Why?
Tayyaba Hasan, Ph.D.Massachusetts General Hospital Why?
Eudocia Quant Lee, M.D.Dana-Farber Cancer Institute Why?
Patrick Yung Chih Wen, M.D.Dana-Farber Cancer Institute Why?
Carla Kim, Ph.D.Boston Children's Hospital Why?
Jonathan Talamo, M.D.Massachusetts Eye and Ear Infirmary Why?
Robert Lawrence Martuza, M.D.Massachusetts General Hospital Why?
Roberto Guillermo Kolter, Ph.D.Harvard Medical School Why?
Jeffrey G. Supko, Ph.D.Massachusetts General Hospital Why?
William Robert Brugge, M.D.Mount Auburn Hospital Why?
Avinash Kambadakone Ramesh, M.D.Massachusetts General Hospital Why?
Per Page    Page  of 19last Nextnext
Prev
Search Criteria
  • Topoisomerase II Inhibitors
Click "Why?" to see why a person matched the search.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.